ES2080854T3 - Uso hipotrigliceridemico de ciertos bis(3,5-di-alquil-4-hidroxifeniltio)metanos. - Google Patents

Uso hipotrigliceridemico de ciertos bis(3,5-di-alquil-4-hidroxifeniltio)metanos.

Info

Publication number
ES2080854T3
ES2080854T3 ES91109943T ES91109943T ES2080854T3 ES 2080854 T3 ES2080854 T3 ES 2080854T3 ES 91109943 T ES91109943 T ES 91109943T ES 91109943 T ES91109943 T ES 91109943T ES 2080854 T3 ES2080854 T3 ES 2080854T3
Authority
ES
Spain
Prior art keywords
hypotriglyceridemic
hidroxifeniltio
alquil
methanes
certain bis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91109943T
Other languages
English (en)
Spanish (es)
Inventor
Simon J T Mao
Richard L Jackson
George Ku
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2080854T3 publication Critical patent/ES2080854T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES91109943T 1990-06-19 1991-06-18 Uso hipotrigliceridemico de ciertos bis(3,5-di-alquil-4-hidroxifeniltio)metanos. Expired - Lifetime ES2080854T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/540,657 US5122542A (en) 1990-06-19 1990-06-19 Hypotriglyceridemic use of certain bis (3,5-di-alkyl-4-hydroxyphenylthio)methanes

Publications (1)

Publication Number Publication Date
ES2080854T3 true ES2080854T3 (es) 1996-02-16

Family

ID=24156398

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91109943T Expired - Lifetime ES2080854T3 (es) 1990-06-19 1991-06-18 Uso hipotrigliceridemico de ciertos bis(3,5-di-alquil-4-hidroxifeniltio)metanos.

Country Status (13)

Country Link
US (1) US5122542A (OSRAM)
EP (1) EP0462556B1 (OSRAM)
JP (1) JPH04230213A (OSRAM)
KR (1) KR0168649B1 (OSRAM)
AT (1) ATE129151T1 (OSRAM)
AU (1) AU640486B2 (OSRAM)
DE (1) DE69113871T2 (OSRAM)
DK (1) DK0462556T3 (OSRAM)
ES (1) ES2080854T3 (OSRAM)
GR (1) GR3018351T3 (OSRAM)
IE (1) IE69315B1 (OSRAM)
TW (1) TW205542B (OSRAM)
ZA (1) ZA914538B (OSRAM)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006063408A1 (en) * 2004-12-17 2006-06-22 Stocker Ronald O Compositions and methods for treating cardiovascular disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4734527A (en) * 1986-10-17 1988-03-29 Merrell Dow Pharmaceuticals Inc. Process for preparing 2,6-di-tertiarybutyl-4-mercaptophenol
US4954528A (en) * 1988-12-08 1990-09-04 Merrell Dow Pharmaceuticals Inc. Hypocholesterolemic use of bis(3,5-di-tertiary-butly-4-hydroxyphenylthio)methane
US4900757A (en) * 1988-12-08 1990-02-13 Merrell Dow Pharmaceuticals Inc. Hypocholesterolemic and antiatherosclerotic uses of bix(3,5-di-tertiary-butyl-4-hydroxyphenylthio)methane
US4959392A (en) * 1989-07-24 1990-09-25 Merrell Dow Pharmaceuticals Inc. Method of treating diabetes mellitus

Also Published As

Publication number Publication date
DE69113871D1 (de) 1995-11-23
DK0462556T3 (da) 1995-11-27
AU7836591A (en) 1992-01-02
JPH04230213A (ja) 1992-08-19
IE912087A1 (en) 1992-01-01
EP0462556A2 (en) 1991-12-27
TW205542B (OSRAM) 1993-05-11
EP0462556A3 (en) 1992-03-11
ATE129151T1 (de) 1995-11-15
AU640486B2 (en) 1993-08-26
KR920000327A (ko) 1992-01-29
IE69315B1 (en) 1996-09-04
ZA914538B (en) 1992-03-25
GR3018351T3 (en) 1996-03-31
KR0168649B1 (ko) 1999-01-15
EP0462556B1 (en) 1995-10-18
US5122542A (en) 1992-06-16
DE69113871T2 (de) 1996-04-04

Similar Documents

Publication Publication Date Title
ES2185711T3 (es) 1,4-benzotiazepina-1,1-dioxidoshipolipimemicos.
ES2176212T3 (es) Eteres de fosfonooximetilicos o metiltiometilicos de derivados de taxano como agentes antitumorales.
MX9301129A (es) Nuevas ciclosporinas y composiciones farmaceuticas que las contienen.
MX9400175A (es) Derivados de fenil tri-substituidos y proceso para su preparacion.
MX9703546A (es) Benzotiazepinas hipolipidemicas.
ES2059446T3 (es) Composicion de copolimero bloque hidrogenado especifico y procedimiento para su fabricacion.
AR004700A1 (es) 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
MX9304581A (es) Desoxitaxoles y composiciones farmaceuticas que los contienen
MY107158A (en) 3-arylcarbonyl; -1h-indoles useful as therapeutic agents.
PT758248E (pt) Formulacoes para o factor ix
ES2161085T3 (es) Formulaciones que contienen oxaliplatino.
AR011734A1 (es) Analogos del peptido lh-rh, y composiciones farmaceuticas que los contienen
ES2098140T3 (es) Liosferas que contienen gonadotropina.
ES2142034T3 (es) Compuestos biaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
ES2065701T3 (es) Furoato de mometasona monohidrato, procedimiento para fabricar el mismo y composiciones farmaceuticas.
ES2115656T3 (es) Analogos de tocoferol cardioprotectores.
ES2143734T3 (es) Compuestos bioaromaticos que llevan un grupo adamantilo en para, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
ES2160680T3 (es) Utilizacion de un antagonista de sustancia p en una composicion farmaceutica.
ES2043665T3 (es) 6,11-dihidro-11-(4-piperidiliden)-5h-benzo-(5,6)-ciclohepta-(1,2-b)-piridinas y composiciones y metodos de uso.
MX9300628A (es) Nuevos derivados de taxano, procedimiento para su preparacion y composicion farmaceutica que los contiene.
ES2115220T3 (es) Nuevo uso de compuestos bis-heterociclicos como agentes antiinflamatorios y composiciones farmaceuticas de los mismos.
ES2032428T3 (es) Procedimiento para preparar (+)-biotina.
CR6398A (es) Antagonistas de 5ht1 para terapia antidepresiva
ES2179529T3 (es) Compuestos biaromaticos unidos por un radical heteroetinileno, y composiciones farmaceuticas y cosmeticas que los contienen.
ES2054881T3 (es) Pantetina como agente inhibidor de la fibrosis hepatica.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 462556

Country of ref document: ES